NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Interpace Biosciences Inc (OTCQX: IDXG)

 
IDXG Technical Analysis
5
As on 9th Jun 2023 IDXG SHARE Price closed @ 1.20 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 3.83 & Strong Sell for SHORT-TERM with Stoploss of 6.50 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

IDXGSHARE Price

Open 0.96 Change Price %
High 1.28 1 Day 0.19 18.81
Low 0.96 1 Week -1.32 -52.38
Close 1.20 1 Month 0.20 20.00
Volume 5705 1 Year -6.55 -84.52
52 Week High 8.50 | 52 Week Low 0.66
 
OTCQX USA Most Active Stocks
OREAF 0.02 -71.43%
RHHBY 39.15 -0.63%
GBTC 13.54 -2.24%
ETHE 7.80 -2.99%
EMHTF 0.04 33.33%
VYGVF 0.15 -6.25%
ZNOG 0.08 14.29%
DANOY 11.58 -2.11%
LGDTF 0.31 -3.12%
CURLF 2.96 -1.33%
 
OTCQX USA Top Gainers Stocks
VVCIF 0.02 100.00%
JRSS 0.07 40.00%
EMHTF 0.04 33.33%
POPRF 0.50 28.57%
POPRF 0.50 28.57%
UGDIF 0.05 25.00%
IDXG 1.20 18.81%
YGTFF 0.07 16.67%
ZNOG 0.08 14.29%
AUMBF 0.08 14.29%
 
OTCQX USA Top Losers Stocks
AKOWF 0.05 -76.19%
OREAF 0.02 -71.43%
ETRGF 0.01 -50.00%
APLIF 0.02 -33.33%
LOWLF 0.03 -25.00%
ZNOGW 1.05 -19.23%
ENZN 0.12 -14.29%
AUXXF 0.12 -14.29%
MACE 0.06 -14.29%
IDAID 4.11 -11.61%
 
 
IDXG
Daily Charts
IDXG
Intraday Charts
Whats New @
Bazaartrend
IDXG
Free Analysis
 
IDXG Important Levels Intraday
RESISTANCE1.82
RESISTANCE1.62
RESISTANCE1.50
RESISTANCE1.37
SUPPORT1.03
SUPPORT0.90
SUPPORT0.78
SUPPORT0.58
 
IDXG Forecast April 2024
4th UP Forecast11.1
3rd UP Forecast7.93
2nd UP Forecast5.96
1st UP Forecast4
1st DOWN Forecast-1.6
2nd DOWN Forecast-3.56
3rd DOWN Forecast-5.53
4th DOWN Forecast-8.7
 
IDXG Weekly Forecast
4th UP Forecast5.63
3rd UP Forecast4.21
2nd UP Forecast3.33
1st UP Forecast2.45
1st DOWN Forecast-0.05
2nd DOWN Forecast-0.93
3rd DOWN Forecast-1.81
4th DOWN Forecast-3.23
 
IDXG Forecast2024
4th UP Forecast17.56
3rd UP Forecast12.31
2nd UP Forecast9.07
1st UP Forecast5.83
1st DOWN Forecast-3.43
2nd DOWN Forecast-6.67
3rd DOWN Forecast-9.91
4th DOWN Forecast-15.16
 
 
IDXG Other Details
Segment EQ
Market Capital 36526436.00
Sector Healthcare
Industry Diagnostics & Research
Offical website >
 
IDXG Address
IDXG
 
IDXG Latest News
 
Your Comments and Response on Interpace Biosciences Inc
 
IDXG Business Profile
Interpace Biosciences, Inc. provides molecular diagnostic tests, bioinformatics, and pathology services for evaluating cancer risk in the United States. The company offers PancraGEN, a pancreatic cyst and pancreaticobiliary solid lesion genomic test that helps physicians better assess risk of pancreaticobiliary cancers using its PathFinderTG platform; and ThyGeNEXT, an oncogenic mutation panel to identify malignant thyroid nodules. It also provides ThyraMIR assesses thyroid nodules for risk of malignancy utilizing a proprietary microRNA gene-expression assay; and RespriDx, a genomic test that helps physicians to differentiate metastatic or recurrent lung cancer. The company also provides pharmacogenomics testing, genotyping, biorepository, and other customized services to the pharmaceutical and biotech industries. It primarily serves physicians, hospitals, and clinics. The company was formerly known as Interpace Diagnostics Group, Inc. and changed its name to Interpace Biosciences, Inc. in November 2019. Interpace Biosciences, Inc. was incorporated in 1986 and is headquartered in Parsippany, New Jersey. Address: Morris Corporate Center 1, Parsippany, NJ, United States, 07054
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service